年別の研究成果
年別の研究成果
研究成果
- 9 Article
検索結果
-
2025
Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort study
Masuda, T., Funakoshi, T., Horimatsu, T., Masui, S., Hira, D., Inoue, M., Yajima, K., Nakagawa, S., Ikemi, Y., Hamanishi, J., Takai, A., Yamamoto, S., Matsubara, T., Mandai, M., Seno, H., Yanagita, M., Muto, M., Terada, T. & Yonezawa, A., 2025 12月, In: Cancer Chemotherapy and Pharmacology. 95, 1, 46.研究成果: Article › 査読
-
2024
Comparison of safety and effectiveness between etanercept biosimilar LBEC0101 and reference in patients with rheumatoid arthritis in real-world data using the KURAMA cohort
Kawakami, T., Masui, S., Onishi, A., Onizawa, H., Fujii, T., Murakami, K., Murata, K., Tanaka, M., Shimada, T., Nakagawa, S., Matsuda, S., Morinobu, A., Terada, T. & Yonezawa, A., 2024 11月 1, In: Modern rheumatology. 34, 6, p. 1135-1141 7 p.研究成果: Article › 査読
Open Access1 被引用数 (Scopus) -
Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series
Masuda, T., Funakoshi, T., Horimatsu, T., Yamamoto, S., Matsubara, T., Masui, S., Nakagawa, S., Ikemi, Y., Yanagita, M., Muto, M., Terada, T. & Yonezawa, A., 2024 10月, In: Cancer Chemotherapy and Pharmacology. 94, 4, p. 615-622 8 p.研究成果: Article › 査読
1 被引用数 (Scopus) -
2023
Serum Concentrations of Infliximab and IL-6 for Predicting One-Year Discontinuation of Infliximab Treatment Owing to Secondary Non-response in Patients with Rheumatoid Arthritis
Masui, S., Yonezawa, A., Nakamura, M., Onishi, A., Hashimoto, M., Onizawa, H., Fujii, T., Murakami, K., Murata, K., Tanaka, M., Yokoyama, K., Iwamoto, N., Shimada, T., Itohara, K., Hira, D., Nakagawa, S., Imai, S., Nakagawa, T., Hayakari, M. & Matsuda, S. & 3 others, , 2023 8月, In: Biological and Pharmaceutical Bulletin. 46, 8, p. 1112-1119 8 p.研究成果: Article › 査読
Open Access -
2022
Infliximab Treatment Persistence among Japanese Patients with Chronic Inflammatory Diseases: A Retrospective Japanese Claims Data Study
Masui, S., Yonezawa, A., Momo, K., Nakagawa, S., Itohara, K., Imai, S., Nakagawa, T. & Matsubara, K., 2022 3月, In: Biological and Pharmaceutical Bulletin. 45, 3, p. 323-332 10 p.研究成果: Article › 査読
Open Access7 被引用数 (Scopus) -
N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4
Masui, S., Yonezawa, A., Yokoyama, K., Iwamoto, N., Shimada, T., Onishi, A., Onizawa, H., Fujii, T., Murakami, K., Murata, K., Tanaka, M., Nakagawa, S., Hira, D., Itohara, K., Imai, S., Nakagawa, T., Hayakari, M., Matsuda, S., Morinobu, A. & Terada, T. & 1 others, , 2022 10月, In: Pharmaceutical research. 39, 10, p. 2541-2554 14 p.研究成果: Article › 査読
1 被引用数 (Scopus) -
2021
Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data
Nakae, K., Masui, S., Yonezawa, A., Hashimoto, M., Watanabe, R., Murata, K., Murakami, K., Tanaka, M., Ito, H., Yokoyama, K., Iwamoto, N., Shimada, T., Nakamura, M., Denda, M., Itohara, K., Nakagawa, S., Ikemi, Y., Imai, S., Nakagawa, T. & Hayakari, M. & 1 others, , 2021 10月, In: PloS one. 16, 10 October, e0258601.研究成果: Article › 査読
Open Access8 被引用数 (Scopus) -
2019
Concentration and Glycoform of Rituximab in Plasma of Patients with B Cell Non-Hodgkin’s Lymphoma
Yonezawa, A., Otani, Y., Kitano, T., Mori, M., Masui, S., Isomoto, Y., Tsuda, M., Imai, S., Ikemi, Y., Denda, M., Sato, Y., Nakagawa, S., Omura, T., Nakagawa, T., Yano, I., Hayakari, M., Takaori-Kondo, A. & Matsubara, K., 2019 6月 1, In: Pharmaceutical research. 36, 6, 82.研究成果: Article › 査読
9 被引用数 (Scopus) -
2018
Analysis of glycoforms and amino acids in infliximab and a biosimilar product using new method with LC/TOF-MS
Tsuda, M., Otani, Y., Yonezawa, A., Masui, S., Ikemi, Y., Denda, M., Sato, Y., Nakagawa, S., Omura, T., Imai, S., Nakagawa, T., Hayakari, M. & Matsubara, K., 2018, In: Biological and Pharmaceutical Bulletin. 41, 11, p. 1716-1721 6 p.研究成果: Article › 査読
Open Access2 被引用数 (Scopus)